138 related articles for article (PubMed ID: 11085108)
1. [Doping].
Kawahara T
Nihon Rinsho; 2000 Sep; 58 Suppl():162-6. PubMed ID: 11085108
[No Abstract] [Full Text] [Related]
2. Ergogenic drugs in sports.
Knopp WD; Wang TW; Bach BR
Clin Sports Med; 1997 Jul; 16(3):375-92. PubMed ID: 9209817
[TBL] [Abstract][Full Text] [Related]
3. [Sports and doping].
Yoshida T
Chudoku Kenkyu; 2003 Jul; 16(3):299-305. PubMed ID: 14582352
[No Abstract] [Full Text] [Related]
4. Drugs in the Olympics.
Med Lett Drugs Ther; 1984 Jul; 26(665):65-6. PubMed ID: 6146092
[No Abstract] [Full Text] [Related]
5. Drugs in sports.
Mofenson HC; Greensher J
N Y State J Med; 1980 Jan; 80(1):57-60. PubMed ID: 6102364
[No Abstract] [Full Text] [Related]
6. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
Sante; 2005; 15(3):167-70. PubMed ID: 16207578
[TBL] [Abstract][Full Text] [Related]
7. Performance enhancement drugs: safe and effective?
Clem JR
S D J Med; 2004 Jun; 57(6):215-6. PubMed ID: 15253475
[No Abstract] [Full Text] [Related]
8. [Doping: effectiveness, consequences, prevention].
Guezennec CY
Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
[TBL] [Abstract][Full Text] [Related]
9. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
[TBL] [Abstract][Full Text] [Related]
10. History of doping and doping control.
Müller RK
Handb Exp Pharmacol; 2010; (195):1-23. PubMed ID: 20020358
[No Abstract] [Full Text] [Related]
11. [Doping--also a problem in general practice?].
Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
[TBL] [Abstract][Full Text] [Related]
12. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
Imanishi T; Kawabata T; Takayama A
Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
[TBL] [Abstract][Full Text] [Related]
13. Substance use in athletics: a sports psychiatry perspective.
McDuff DR; Baron D
Clin Sports Med; 2005 Oct; 24(4):885-97, ix-x. PubMed ID: 16169452
[TBL] [Abstract][Full Text] [Related]
14. Performance-enhancing drugs.
Med Lett Drugs Ther; 2004 Jul; 46(1187):57-9. PubMed ID: 15263874
[No Abstract] [Full Text] [Related]
15. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
16. [Point of view on doping].
Naeije R; Pagnamenta A
Rev Med Brux; 1999 Jun; 20(3):153-8. PubMed ID: 10429539
[TBL] [Abstract][Full Text] [Related]
17. [Doping].
Clasing D
Internist (Berl); 1986 Dec; 27(12):785-93. PubMed ID: 2880826
[No Abstract] [Full Text] [Related]
18. Sports pharmacology and ergogenic aids.
Ellender L; Linder MM
Prim Care; 2005 Mar; 32(1):277-92. PubMed ID: 15831323
[TBL] [Abstract][Full Text] [Related]
19. American College of Sports Medicine position stand on the use of anabolic-androgenic steroids in sports.
Med Sci Sports Exerc; 1987 Oct; 19(5):534-9. PubMed ID: 3316907
[No Abstract] [Full Text] [Related]
20. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
Thevis M; Schänzer W
Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
